Maharsh Patel, MD
Hand Surgery · Macon, GANPI 1285052977
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Axogen at 37.6% of the total.
Across 41 payments — averaging $114.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- United Orthopedics LLC$915
- Arthrex$506
- Linvatec Corporation$304
- Skeletal Dynamics Inc$289
- Innovation Technologies Inc$214
- plus $711 from 10 others
What the payments were for
- Travel & lodging$2,60655%
- Food & beverage$2,10645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 4 | $1,772 |
| United Orthopedics LLC | 4 | $915 |
| Arthrex | 3 | $506 |
| Linvatec Corporation | 2 | $304 |
| Skeletal Dynamics Inc | 3 | $289 |
| Innovation Technologies Inc | 4 | $214 |
| Amgen(2 entities) | 2 | $146 |
| Johnson & Johnson | 2 | $136 |
| Trimed, Inc. | 1 | $106 |
| Endo Pharmaceuticals Inc. | 5 | $87 |
| Organogenesis Inc. | 2 | $75 |
| Endo USA, Inc. | 3 | $55 |
| Anika Therapeutics, Inc. | 2 | $40 |
| Davol Inc. | 2 | $31 |
| KCI USA, Inc. | 1 | $22 |
| Acumed LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Protector$1,754
- AxoGuard Nerve Connector$1,754
- BioBrace 23mm$304
- Geminus$259
- Align$259
- IJS$259
- Implate$259
- HALL POWER$152
- Irrisept$151
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$104
- IM NAILS$104
How this compares
$4,712 in reported general payments places this provider in the 70th percentile of 77 hand surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 134 | $916 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $88 |
| Meloxicam | 29 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $62 |
| Tramadol Hcl | 23 | $42 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Macon
- Yelena LevinaMacon$15K
- John SappMacon$901
- Eric WagnerAtlanta$173K
- Phani DantuluriAtlanta$120K
- Gregory KolovichSavannah$103K
- Michael ShulerAthens$99K
- Travis LittletonAtlanta$35K
- Nicole ZelenskiAtlanta$34K
- Justin BarrettGainesville$33K
- Tobias von BergenStockbridge$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.